Type(s) of Cancer
Lung
Lung
Study Phase
Phase 3
Study Completion Date
June 2013
June 2013
NCT00981058Uploaded 10-16-2018
Available for Download
PDS UID: LungNo_EliLill_2010_272
A Randomized, Multicenter, Open-Label Phase 3 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Gemcitabine-Cisplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
Files:




PROTOCOLV6-0 Protocol CP11-0806-redact_v3.pdf

CRFjfcc_acrf_redacted.pdf

DATA DICTIONARYjfcc_adam_define_redacted.pdf

DATA (COMPARATOR ARM)jfcc_deid_ctrl_trt.zip